Correlation Between Allogene Therapeutics and Anixa Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Anixa Biosciences, you can compare the effects of market volatilities on Allogene Therapeutics and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Anixa Biosciences.

Diversification Opportunities for Allogene Therapeutics and Anixa Biosciences

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Allogene and Anixa is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Anixa Biosciences go up and down completely randomly.

Pair Corralation between Allogene Therapeutics and Anixa Biosciences

Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Anixa Biosciences. In addition to that, Allogene Therapeutics is 1.13 times more volatile than Anixa Biosciences. It trades about -0.06 of its total potential returns per unit of risk. Anixa Biosciences is currently generating about 0.01 per unit of volatility. If you would invest  356.00  in Anixa Biosciences on September 1, 2024 and sell it today you would lose (26.00) from holding Anixa Biosciences or give up 7.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Allogene Therapeutics  vs.  Anixa Biosciences

 Performance 
       Timeline  
Allogene Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Allogene Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Allogene Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Anixa Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Anixa Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Anixa Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Allogene Therapeutics and Anixa Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allogene Therapeutics and Anixa Biosciences

The main advantage of trading using opposite Allogene Therapeutics and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.
The idea behind Allogene Therapeutics and Anixa Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets